Back to search

Article

Comparative Effectiveness of Dexamethasone in Treatment of Hospitalized COVID-19 Patients during the First Year of the Pandemic: The N3C Data Repository

2022-10-24

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Dexamethasone, a widely available glucocorticoid, was approved for use in hospitalized COVID-19 patients early in the pandemic based on the RECOVERY trial; however, evidence is still needed to support its real-world effectiveness in patients with a wide range of comorbidities and in diverse care settings. <h4>Objectives</h4> To conduct a comparative effectiveness analysis of d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18df35f4-a248-52d5-82ac-9a3131176918
DOI
10.1101/2022.10.22.22281373
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Effectiveness of Dexamethasone in Treatment of Hospitalized COVID-19 Patients during the First Year of the Pandemic: The N3C Data RepositoryDOI 10.1101/2022.10.22.22281373
Ruxolitinib Versus Dexamethasone in Hospitalized Adults With COVID-19: Multicenter Matched Cohort StudySemantic proximity
‘Which severe COVID-19 patients could benefit from High dose dexamethasone? A Bayesian reanalysis of a randomized clinical trialSemantic proximity
Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled studySemantic proximity
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic dataSemantic proximity
Remdesivir as a tool to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impactSemantic proximity
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort studySemantic proximity
Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large State-wide Health System During the Pandemic in 2020Semantic proximity
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection.Semantic proximity
Real-World Effectiveness of Casirivimab and Imdevimab Among Patients Diagnosed With COVID-19 in the Ambulatory Setting: A Retrospective Cohort Study Using a Large Claims DatabaseSemantic proximity
Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity
Credible learning of hydroxychloroquine and dexamethasone effects on COVID-19 mortality outside of randomized trialsSemantic proximity
Impact of remdesivir for the treatment of COVID-19 during the first wave in SpainSemantic proximity
Select a neighboring publication to make it the new centre.